Earnings · China A-shares
Hunan Nucien Pharmaceutical Co. Ltd. Class A (688189) earnings
Hunan Nucien Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-30: net profit +8.11% year on year, +10.71% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +4.34% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- +8.11%
- Excl. one-offs YoY
- +10.71%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +2.95% | — |
| 3 days | +4.34% | — |
| 7 days | +9.90% | — |
| 14 days | +0.69% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 6 of 6 reports (average +5.04%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥63.07M | +8.11% | +10.71% | +10.86% | -0.23 | -8.25% | +4.34% | — | — |
| 2026 interim report | 2026-08-31 | -¥37.16M | +7.10% | +14.06% | -9.38% | -0.14 | -4.87% | +3.63% | -7.55% | +1.78% |
| 2026 Q1 report | 2026-04-30 | -¥13.24M | -64.96% | -62.30% | -35.88% | -0.05 | -1.74% | +7.22% | -27.65% | -29.70% |
| 2025 annual report | 2026-04-30 | -¥136.90M | +60.49% | +60.26% | -43.62% | -0.50 | -16.94% | +7.22% | -27.65% | -29.70% |
| 2025 Q3 report | 2025-10-31 | -¥68.63M | -39.19% | -15.17% | -66.89% | -0.25 | -7.64% | +10.05% | +0.84% | +5.52% |
| 2025 interim report | 2025-08-29 | -¥40.00M | -493.23% | — | -71.28% | -0.15 | -4.37% | +0.06% | -48.41% | -49.68% |
| 2025 Q1 report | 2025-04-30 | -¥8.03M | -143.66% | — | -70.21% | -0.03 | -0.86% | +4.94% | +28.34% | +25.16% |
| 2024 annual report | 2025-04-30 | -¥346.51M | -1529.30% | — | -61.59% | -1.26 | -31.08% | +4.94% | +28.34% | +25.16% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.